Cancer Clinical Trial
Official title:
Identification and Treatment of Depression in Underserved African American and Latino Patients With Cancer
The goal of this research study is to learn how well a telephone system works for improving the management of emotional distress, sadness, and/or depression in patients who are being treated for cancer.
Study Groups:
If you agree to take part in this study, you will be randomly assigned (as in the flip of a
coin) to 1 of 2 groups: telephone intervention or standard care. You have an equal chance of
being assigned to either group.
No matter which group you are assigned to, you will be asked to tell your doctor and/or nurse
about all symptoms you may be experiencing during your regularly scheduled visits. You will
also be asked to call your doctor and/or nurse right away when your symptoms are severe. The
doctor and/or nurse will give you instructions about calling when your symptoms are severe.
You will receive educational material about emotional distress, sadness, and depression in
people who are being treated for cancer. The material also will tell you about community
resources that are available for people with cancer.
Feedback Group:
If you are assigned to the feedback group, your symptom information will be collected using a
telephone system. You will be asked to rate 13 symptoms, such as sadness, emotional distress,
and fatigue, on a scale of 0 to 10 using the touch tone key pad of your telephone. The 0
means that you are not having the symptom at all, and the 10 means that the symptom is as bad
as you can imagine.
If you rate either of the 2 symptoms of sadness and/or emotional distress as moderate or
severe, then the telephone system will send a message to the research staff and your doctor
or nurse right away. Only the symptoms of sadness and emotional distress will be reported
right away to the doctor or nurse and the research staff. If you answer moderate to severe to
any other questions, it will not be sent right away to the doctor, nurse or study staff. The
telephone system usually works very well. But, if for any reason the telephone system is not
working, the research staff will report any moderate or severe sadness or distress to your
doctor or nurse. Your doctor or nurse also will receive a written summary of your symptom
ratings before your next clinic visit.
Standard Care Group:
If you are assigned to the standard care group, your symptom information will not be
collected using the telephone system. You will be asked to tell your doctor and/or nurse
about all symptoms you may be experiencing.
Telephone System:
For patients in the feedback group, the research staff will teach you how to use a telephone
system for measuring your symptoms. The research staff also will ask you to practice using
the telephone system. The telephone system will call you 1 time a week for 16 weeks. You will
be asked to rate your symptoms and how much the symptoms interfere with your life. You can
set up a time to receive the phone calls that works best for you. Rating your symptoms using
the telephone system will take about 5 minutes for each call.
If you do not answer the telephone system on the first call, then the system will try to
reach you 3 more times. If you do not answer after the fourth try, then the research staff
will call you to find out why you could not answer the telephone system. If you prefer, the
research staff will change the day or time that the telephone system calls you.
Questionnaires and Interviews:
You will be asked to fill out 3 questionnaires during 3 regularly scheduled clinic visits.
These questionnaires ask questions about pain, stress, sadness, quality of life, and other
symptoms you may be experiencing. You will also compete an interview at the first and third
visit. During the interview, you will be asked questions about your feelings and emotions.
The questionnaires and interview will be completed at the following times:
- At the first visit when you enroll in the study, 8-10 weeks after the study begins, and
14-16 weeks after the study begins, you will complete the questionnaires. This will take
about 45 minutes.
- At the first visit and 14-16 weeks after the study begins, you will complete a short
interview. Completing the interview will take about 15 minutes.
Length of Study:
Your participation in this study will last up to 16 weeks.
This is an investigational study.
Up to 166 patients will take part in this study. All will be enrolled at MD Anderson.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|